8095 Stock Overview
Manufactures and sells medicine-related products in Japan. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
My Notes
Capture your thoughts, links and company narrative
Astena Holdings Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥471.00 |
| 52 Week High | JP¥576.00 |
| 52 Week Low | JP¥417.00 |
| Beta | 0.043 |
| 1 Month Change | -6.55% |
| 3 Month Change | -8.72% |
| 1 Year Change | 1.07% |
| 3 Year Change | -1.26% |
| 5 Year Change | 2.39% |
| Change since IPO | -7.47% |
Recent News & Updates
Astena Holdings (TSE:8095) Has Affirmed Its Dividend Of ¥9.00
Oct 17
Astena Holdings Co., Ltd.'s (TSE:8095) Revenues Are Not Doing Enough For Some Investors
Aug 07Shareholder Returns
| 8095 | JP Pharmaceuticals | JP Market | |
|---|---|---|---|
| 7D | -2.1% | -1.2% | -0.9% |
| 1Y | 1.1% | 9.8% | 13.7% |
Return vs Industry: 8095 underperformed the JP Pharmaceuticals industry which returned 9.8% over the past year.
Return vs Market: 8095 underperformed the JP Market which returned 13.7% over the past year.
Price Volatility
| 8095 volatility | |
|---|---|
| 8095 Average Weekly Movement | 2.7% |
| Pharmaceuticals Industry Average Movement | 3.8% |
| Market Average Movement | 3.6% |
| 10% most volatile stocks in JP Market | 7.4% |
| 10% least volatile stocks in JP Market | 1.9% |
Stable Share Price: 8095 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 8095's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1914 | 1,404 | Satoshi Setoguchi | www.astena-hd.com |
Astena Holdings Co., Ltd. manufactures and sells medicine-related products in Japan. The company’s Fine Chemical division deals in the chemistry, manufacturing and control (CMC)/contract development and manufacturing organization (CDMO) and procurement platform businesses; and offers services for pharmaceutical development and manufacturing, from raw ingredient procurement to CMC research and development and commercial API production for antipyretic, analgesic and anti-inflammatory, and vasoconstrictor areas. The company’s Health & Beauty Care, and Food division delivers OTC drugs, functional food and cosmetic ingredients, and conducts mail-order sales of cosmetics and OEM products, including 1,3-butylene glycol, sodium acetylated hyaluronate, yeast extract, tomato powder, natural plant extract, natural plant extract, dehydrate potato, and meat extract powder.
Astena Holdings Co., Ltd. Fundamentals Summary
| 8095 fundamental statistics | |
|---|---|
| Market cap | JP¥18.96b |
| Earnings (TTM) | JP¥2.09b |
| Revenue (TTM) | JP¥53.39b |
9.1x
P/E Ratio0.4x
P/S RatioIs 8095 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 8095 income statement (TTM) | |
|---|---|
| Revenue | JP¥53.39b |
| Cost of Revenue | JP¥35.18b |
| Gross Profit | JP¥18.21b |
| Other Expenses | JP¥16.12b |
| Earnings | JP¥2.09b |
Last Reported Earnings
Aug 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 51.94 |
| Gross Margin | 34.11% |
| Net Profit Margin | 3.92% |
| Debt/Equity Ratio | 53.7% |
How did 8095 perform over the long term?
See historical performance and comparisonDividends
3.8%
Current Dividend Yield51%
Payout RatioDoes 8095 pay a reliable dividends?
See 8095 dividend history and benchmarks| Astena Holdings dividend dates | |
|---|---|
| Ex Dividend Date | Nov 28 2024 |
| Dividend Pay Date | Feb 28 2025 |
| Days until Ex dividend | 22 days |
| Days until Dividend pay date | 70 days |
Does 8095 pay a reliable dividends?
See 8095 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/19 18:00 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/08/31 |
| Annual Earnings | 2023/11/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Astena Holdings Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Hisaki Hatori | Mizuho Securities Co., Ltd. |